Selenium in oncology - An update

Trace Elements and Electrolytes

Volumn 27, Issue 4, 2010, Pages 250-257

  Micke, O ^a   Schomburg, L ^b   Buentzel, J ^c   Kisters, K ^d   Muecke, R ^e  

^a FRANZISKUS HOSPITAL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Südharz Hospital Nordhausen   (Germany)

^d ST ANNA HOSPITAL   (Germany)

^e Lippe Hospital Lemgo   (Germany)

Author keywords

Cancer prevention; Cytoprotection; Oncology; Radical scavenger; Radioprotection; Selenium

Indexed keywords

ALPHA TOCOPHEROL; AMIFOSTINE; CARMUSTINE; METHYLSELENINIC ACID; POTASSIUM CYANATE; POTASSIUM DERIVATIVE; SELENITE; SELENIUM; SELENOCYSTAMIN; SELENOCYSTINE; SELENODIGLUTATHIONE; SELENOMETHIONINE; SODIUM SELENITE; UNCLASSIFIED DRUG; VITAMIN;

APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; BIOCHEMISTRY; BREAST CANCER; CANCER PATIENT; CANCER PREVENTION; CELL PROTECTION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; DIABETES CONTROL; DIARRHEA; DRUG EFFECT; EHRLICH ASCITES TUMOR; ENDOLARYNGEAL EDEMA; ENDOMETRIUM CANCER; HUMAN; IN VITRO STUDY; LYMPHEDEMA; LYMPHOMA CELL; MUCOSA INFLAMMATION; NONHUMAN; ONCOLOGY; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION INJURY; RADIATION PROTECTION; RADIOSENSITIZATION; RISK; SELENIUM DEFICIENCY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; SUBCUTANEOUS TISSUE TUMOR; SUPPLEMENTATION; SURVIVAL; UTERINE CERVIX CANCER;

ANIMALIA;

EID: 77958604378     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/tep27250     Document Type: Article

References (56)

1. Büntzel J, Kisters K, Micke O, Mücke R. Zytoprotektion, Spurenelemente und Elektrolyte in der Tumortherapie. München - Orlando: Dustri; 2004.
2. Wassermann Av, Keysser F, Wassermann M. Beiträge zum Problem: Geschwülste von der Blutbahn aus therapeutisch zu beeinflussen. Dtsch Med Wschr. 1911; 37: 2389-2391.
3. rd edition. Heidelberg: Barth; 1998.
4. Walker CH, Klein F. Selenium - its therapeutic value, especially in cancer. Am Med. 1915; 21: 628-632.
5. Watson-Williams E. The treatment of inoperable cancer with selenium. Brit J Surg. 1920; 8: 50-58.
6. Weissberger AS, Suhrland LG. Studies on analogues of L-cysteine and L-cystine. III. The effect of selenium cystine on leukemia. Blood. 1956; 11: 19-30.
7. Schomburg L, Koehrle J. Selenium: benefits and risks. MMW Fortschr Med. 2007; 149: 34-36.
8. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal. 2007; 9: 775-806.
9. Xia Y, Hill KE, Byrne DW, Xu J, Burk RF. Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr. 2005; 8: 829-834.
10. Schomburg L, Schweizer U. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim Biophys Acta Mar. 2009; 25: S0006-3002 (epub ahead of print).
11. Burk RF, Hill KE, Motley AK. Plasma selenium in specific and non-specific forms. Biofactors 2001; 14: 107-114.
12. Coombs GF Jr. Selenium in global food systems. Br J Nutr. 2001; 85: 517-547.
13. Rayman MP. The importance of selenium to human health. Lancet. 2000; 356: 233-241.
14. Weiss JF, Landauer MR. History and development of radiation-protective agents. Int J Radiat Biol. 2009; 85: 539-573.
15. Patchen ML, MacVittie TJ, Weiss JF. Combined modality radioprotection: the use of glucan and selenium with WR-2721. Int J Radiat Oncol Biol Phys. 1990; 18: 1069-1075.
16. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci. 2000; 57: 1825-1835.
17. Epp O, Ladenstein R, Wendel A. The refined structure of the selenoenzyme glutathione peroxidase at 0.2 nm resolution. Eur J Biochem. 1983; 133: 51-69.
18. Zhung W, Yan T, Lim R, Oberley LW. Expression of superoxide dismutases, catalase, and glutathione peroxidase in glioma cells. Free Radic Biol Med. 1999; 27: 1334-1345. (Pubitemid 30001496)
19. Mutlu-Türkoglu Ü, Erbil Y, Öztezcan S et al. The effect of selenium and/or vitamin E treatments on radiation-induced intestinal injury in rats. Life Sciences. 2000; 66: 1905-1913. (Pubitemid 30213164)
20. Hehr T, Bamberg M, Rodemann HP. Präklinische und klinische Relevanz der radioprotektiven Wirkung von Natriumselenit. InFoOnkologie. 1999; 2 (Suppl): 25-29.
21. Schleicher UM, Lopez Cotarelo C, Andreopoulos Det al. Radioprotection of human endothelial cells by sodium selenite. Med Klin. (Munich) 1999; 94 (Suppl): 35-38.
22. Gehrisch A, Dörr W. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa. Strahlenther Onkol. 2007; 183: 36-42. (Pubitemid 46144103)
23. Margulies BS, Damron TA, Allen MJ. The differential effects of the radioprotectant drugs amifostine and sodium selenite treatment in combination with radiation therapy on constituent bone cells, Ewing's sarcoma of bone tumor cells, and rhabdomyosarcoma tumor cells in vitro. J Orthop Res. 2008; 26: 1512-1519.
24. Stewart MS, Spallholz JE, Neldner KH, Pence BC. Selenium compounds have disparate abilities to impose oxidative stress and include apoptosis. Free Radic Biol Med. 1999; 26: 42-48.
25. Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med. 1994; 17: 45-64.
26. Lanfear J, Fleming J, Wu L et al. The selenium metabolite selenoglutathione induces p53 and apoptosis: relevance to the chemoprotective effects of selenium? Carcinogenesis. 1994; 15: 1387-1392.
27. Davis RL, Spallholz JE. Inhibition of selenite-catalyzed superoxide generation and formation of elemental selenium (Se0) by copper, zinc, and aurintricarboxylic acid (ATA). Biochem Pharmacol. 1996; 51: 1015-1020.
28. Lu JX, Kaeck M, Jiang C, Wilson AC, Thompson HJ. Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol. 1994; 47: 1531-1535. (Pubitemid 24167263)
29. Frisk P, Saetre A, Couze B et al. Effects of Pb2+, Ni2+, Hg2+ and Se4+ on cultured cells. Analysis of uptake, toxicity and influence on radiosensitivity. BioMetals. 1997; 10: 263-270.
30. Schüller P, Püttmann S, Micke O et al. Selenium - A novel radiosensitizer? Trace Elem Elec. 2005; 22: 201-206.
31. Rodemann HP, Hehr T, Bamberg M. Relevance of the radioprotective effect of sodium selenite. Med Klin (Munich). 1999; 94 (Suppl): 39-41.
32. Schüller P, Püttmann S, Micke O et al. Selenium influences the radiation sensitivity of C6 rat glioma cells. Anticancer Res. 2004; 24: 2913-2917. (Pubitemid 39407166)
33. Dörr W. Effects of selenium on radiation responses of tumor cells and tissue. Strahlenther. Onkol. 2006; 182: 693-695.
34. Büntzel J, Glatzel M, Bruns F et al. Selenium supplementation in head and neck surgery. Trace Elem Elec. 2008; 25: 221.
35. Micke O, Büntzel J, Bruns F et al. Clinical elementology in oncology: Experiences and proposals from Germany. Trace Elem Elec. 2008; 25: 221.
36. Last KW, Cornelius V, Delves T et al. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2003; 21: 2335-2341. (Pubitemid 46621872)
37. Last K, Maharaj L, Perry J et al. The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann Oncol. 2006; 17: 773-779.
38. Fraunholz I, Eberlein K, Schopohl B et al. Selenium levels during the course of radiotherapy. No influence of irradiation on blood selenium concentration. Strahlenther Onkol. 2008; 184: 411-415.
39. Büntzel J, Mücke R, Micke O. Mineral status and enzymatic antioxidative capacities during radiochemotherapy in patients with advanced head and neck cancer. Trace Elem Elec. 2000; 18: 98.
40. Micke O, Bruns F, Mücke R et al. Selenium in the treatment of radiation-associated secondary lymphedema. Int J Radiat Oncol Biol Phys. 2003; 56: 40-49. (Pubitemid 36403675)
41. Mücke R, Büntzel J, Glatzel M et al. Postoperative serum and whole blood selenium levels in patients with squamous cell and adenocarcinomas of the uterus after curative surgical treatment. Trace Elem Elec. 2009; 26: 78-82.
42. Mücke R, Glatzel M, Bernd-Skorka R et al. Multicenter, phase-III study comparing selenium supplementation with observation in gynecologic radiation oncology. Int Radiat Oncol Biol Phys. 2010; in press.
43. Bruns F, Büntzel J, Mücke R, Schönekaes K, Kisters K, Micke O. Selenium in the treatment of head and neck lymphedema. Med Princ Pract. 2004; 13: 185-190. (Pubitemid 38812932)
44. Kasseroller R. Sodium selenite as prophylaxis against erysipelas in secondary lymphedema. Anticancer Res. 1998; 18: 2227-2230. (Pubitemid 28386495)
45. Brenke, R, Siems W, Grune T. Measures for therapy optimization in chronic lymphedema. Z Lymphol. 1997; 21: 1-29.
46. Schrauzer GN. Selenium in the therapy of chronic lymphedema - mechanistic perspectives and practical applications. Z Lymphol. 1997; 21: 16-19.
47. Miller S, Walker SW, Arthur JR et al. Selenite protects human endothelial cells from oxidative damage and induces thioredoxin reductase. Clin Sci. 2001; 100: 543-550. (Pubitemid 32434120)
48. Shamberger RJ, Frost DV. Possible protective effect of selenium against human cancer. Can Med Assoc J. 1969; 100: 682.
49. Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ, Zhang QN, Hou C. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res. 1991; 29: 289-294.
50. Clark LC, Combs GF, Turnbull BW et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996; 276: 1957-1963.
51. Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med. 2008; 168: 404-410.
52. Lippman SM, Klein EA, Goodman PJ et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2009; 301: 39-51.
53. Coombs GF Jr. Selenium in global food systems. Br J Nutr. 2001; 85: 517-547.
54. Stranges S, Marshall JR, Natarajan R et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007; 147: 217-223.
55. Gann PH. Randomized trials of antioxidant supplementation for cancer prevention: first bias, now chance - next, cause. JAMA.2009; 301: 102-103.
56. Dennert G, Horneber M. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. Cochrane Database Syst Rev. 2006; 3: CD005037.